Additionally, it highlights the potential of neutrophils as delivery systems for cancer therapies, underscoring the need to unravel tumor-associated neutrophil functions and LAP mechanisms to inform novel and effective cancer treatments. The gene discussed is TGFB1; the disease is neoplasm.